| Dr Mary Beth J Steinfeld, MD | |
|
2825 50th St, Uc Davis Department Of Pediatrics, Sacramento, CA 95817-2308 | |
| (916) 703-0271 | |
| (916) 703-0243 |
| Full Name | Dr Mary Beth J Steinfeld |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Developmental - Behavioral Pediatrics |
| Location | 2825 50th St, Sacramento, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003891334 | NPI | - | NPPES |
| 00G0596760 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0006X | Pediatrics - Developmental - Behavioral Pediatrics | G059676 (California) | Primary |
| Entity Name | Regents Of The Univ Of Ca |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013906973 PECOS PAC ID: 3375456619 Enrollment ID: O20031111000892 |
News Archive
This year, more than 230,000 women will be diagnosed with breast cancer and nearly 40,000 women will not survive their battle with cancer, according to the American Cancer Society. New research from the University of Missouri shows that certain factors, including marital status, having children in the home, income level and age, affect the likelihood of depression in breast cancer survivors.
NEW research, led by Loughborough University academics, has found that tropical cyclones followed by deadly heat is an emerging weather threat that could put millions of people at risk as global temperatures continue to rise.
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced that it has completed enrollment of its APEX-PD trial. APEX-PD is a multinational Phase III trial of its late-stage drug candidate IPX066 in subjects with early Parkinson's disease.
New research aims to estimate the benefits of different ways to carry out screening both patients with tuberculosis (TB) for diabetes and the other way around in parts of the world where both diseases are common.
The MEDICREA Group, listed on Alternext by NYSE Euronext Paris, a medical device company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, reaffirmed its ambitious marketing schedule today for GRANVIA-C, its next-generation cervical disc prosthesis, and also announced the launch of a pre-IDE pilot trial with a view to initiating the approval process in the United States.
› Verified 9 days ago
| Entity Name | County Of Sacramento |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366513061 PECOS PAC ID: 0345231247 Enrollment ID: O20050405000747 |
News Archive
This year, more than 230,000 women will be diagnosed with breast cancer and nearly 40,000 women will not survive their battle with cancer, according to the American Cancer Society. New research from the University of Missouri shows that certain factors, including marital status, having children in the home, income level and age, affect the likelihood of depression in breast cancer survivors.
NEW research, led by Loughborough University academics, has found that tropical cyclones followed by deadly heat is an emerging weather threat that could put millions of people at risk as global temperatures continue to rise.
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced that it has completed enrollment of its APEX-PD trial. APEX-PD is a multinational Phase III trial of its late-stage drug candidate IPX066 in subjects with early Parkinson's disease.
New research aims to estimate the benefits of different ways to carry out screening both patients with tuberculosis (TB) for diabetes and the other way around in parts of the world where both diseases are common.
The MEDICREA Group, listed on Alternext by NYSE Euronext Paris, a medical device company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, reaffirmed its ambitious marketing schedule today for GRANVIA-C, its next-generation cervical disc prosthesis, and also announced the launch of a pre-IDE pilot trial with a view to initiating the approval process in the United States.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mary Beth J Steinfeld, MD 3346 Sierra Oaks Dr, Sacramento, CA 95864-5729 Ph: (916) 703-0271 | Dr Mary Beth J Steinfeld, MD 2825 50th St, Uc Davis Department Of Pediatrics, Sacramento, CA 95817-2308 Ph: (916) 703-0271 |
News Archive
This year, more than 230,000 women will be diagnosed with breast cancer and nearly 40,000 women will not survive their battle with cancer, according to the American Cancer Society. New research from the University of Missouri shows that certain factors, including marital status, having children in the home, income level and age, affect the likelihood of depression in breast cancer survivors.
NEW research, led by Loughborough University academics, has found that tropical cyclones followed by deadly heat is an emerging weather threat that could put millions of people at risk as global temperatures continue to rise.
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced that it has completed enrollment of its APEX-PD trial. APEX-PD is a multinational Phase III trial of its late-stage drug candidate IPX066 in subjects with early Parkinson's disease.
New research aims to estimate the benefits of different ways to carry out screening both patients with tuberculosis (TB) for diabetes and the other way around in parts of the world where both diseases are common.
The MEDICREA Group, listed on Alternext by NYSE Euronext Paris, a medical device company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, reaffirmed its ambitious marketing schedule today for GRANVIA-C, its next-generation cervical disc prosthesis, and also announced the launch of a pre-IDE pilot trial with a view to initiating the approval process in the United States.
› Verified 9 days ago
Lena Claire Van Der List, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 2516 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-2428 | |
Lindalee G Huston, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5301 F St, #220, Sacramento, CA 95819 Phone: 916-455-8000 Fax: 916-733-6088 | |
Alison My Lam, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2516 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-3665 | |
Marcela Lau, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2025 Morse Ave, Sacramento, CA 95825 Phone: 916-973-5000 | |
Donald Morley Null, Jr., MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2315 Stockton Blvd, Nicu, Sacramento, CA 95817 Phone: 916-703-3050 Fax: 916-703-3055 | |
Dr. Elizabeth Partridge, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2516 Stockton Blvd, Sacramento, CA 95817 Phone: 510-428-4337 |